Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
GALNT3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CASC4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DIRC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SACM1L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PSMD10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CRLS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PAK2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC30A5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EIF4E3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MRPL42 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C5orf24 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TOP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SC5D - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DPY19L4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EGLN3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BAG2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ERMP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
STYX - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
B3GALNT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on